| Business Summary |
| A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders, with exclusive worldwide commercial rights to two product candidates in clinical development. |
| General Information |
9605 Medical Center Drive
Suite 300
Rockville, MD 20850
|
| www.vandapharmaceuticals.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 24 |
| CEO: Dr. Mihael Hristos Polym |
| Short Interest |
| Current Month (Mil) |
3.73 |
| Previous Month (Mil) |
2.97 |
| Short Interest Ratio (Days) |
2.10 |
| Management Effectiveness |
| Return on Equity |
n.a. |
| Return on Assets |
-89.10 |
| Return on Investments |
-116.00 |
| Profitability |
| Gross Margin |
n.a. |
| EBIT Margin |
n.a. |
| Profit Margin |
0.00 |
Connect with TheStreet